Investigational Drug Information for Verinurad
✉ Email this page to a colleague
What is the drug development status for Verinurad?
Verinurad is an investigational drug.
There have been 9 clinical trials for Verinurad.
The most recent clinical trial was a Phase 2 trial, which was initiated on May 19th 2020.
The most common disease conditions in clinical trials are Renal Insufficiency, Chronic, Kidney Diseases, and Hyperuricemia. The leading clinical trial sponsors are AstraZeneca, Parexel, and PAREXEL Early Phase Clinical Unit-Los Angeles.
There are twelve US patents protecting this investigational drug and one hundred and eighty international patents.
Summary for Verinurad
US Patents | 12 |
International Patents | 180 |
US Patent Applications | 35 |
WIPO Patent Applications | 17 |
Japanese Patent Applications | 9 |
Clinical Trial Progress | Phase 2 (2020-05-19) |
Vendors | 47 |
Recent Clinical Trials for Verinurad
Title | Sponsor | Phase |
---|---|---|
A Study in Healthy Subjects to Assess Drug Availability of 4 Different Formulations of Verinurad and Allopurinol | Parexel | Phase 1 |
A Study in Healthy Subjects to Assess Drug Availability of 4 Different Formulations of Verinurad and Allopurinol | AstraZeneca | Phase 1 |
Pharmacokinetics of Verinurad and Allopurinol in Combination With Cyclosporine and Rifampicin in Healthy Volunteers | Parexel | Phase 1 |
Clinical Trial Summary for Verinurad
Top disease conditions for Verinurad
Top clinical trial sponsors for Verinurad
US Patents for Verinurad
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
Verinurad | ⤷ Try a Trial | 3,4-di-substituted pyridine compound, methods of using and compositions comprising the same | ARDEA BIOSCIENCES, INC. (San Diego, CA) | ⤷ Try a Trial |
Verinurad | ⤷ Try a Trial | Condensed ring derivative, and preparation method, intermediate, pharmaceutical composition and use thereof | SHANGHAI YINGLI PHARMACEUTICAL CO., LTD. (Shanghai, CN) | ⤷ Try a Trial |
Verinurad | ⤷ Try a Trial | Condensed ring derivative, and preparation method, intermediate, pharmaceutical composition and use thereof | SHANGHAI YINGLI PHARMACEUTICAL CO., LTD. (Shanghai, CN) | ⤷ Try a Trial |
Verinurad | ⤷ Try a Trial | Controlled release dosage form | TRIASTEK, INC. (Nanjing, CN) | ⤷ Try a Trial |
Verinurad | ⤷ Try a Trial | URAT1 inhibitor | Nippon Chemiphar Co., Ltd. (Tokyo, JP) J-Pharma Co., Ltd. (Kanagawa, JP) DeThree Res. Lab. Inc. (Ibaraki, JP) | ⤷ Try a Trial |
Verinurad | ⤷ Try a Trial | Thioacetate compounds, compositions and methods of use | Ardea Biosciences, Inc. (San Diego, CA) | ⤷ Try a Trial |
Verinurad | ⤷ Try a Trial | Quinoline compounds, preparation methods thereof, and uses thereof as urate transporter inhibitor drug | HINOVA PHARMACEUTICALS INC. (Chengdu, Sichuan, CN) | ⤷ Try a Trial |
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Verinurad
Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
---|---|---|---|---|
Verinurad | Australia | AU2012332154 | 2031-11-03 | ⤷ Try a Trial |
Verinurad | Brazil | BR112014010495 | 2031-11-03 | ⤷ Try a Trial |
Verinurad | Canada | CA2852490 | 2031-11-03 | ⤷ Try a Trial |
Verinurad | China | CN104023723 | 2031-11-03 | ⤷ Try a Trial |
Verinurad | China | CN106963761 | 2031-11-03 | ⤷ Try a Trial |
Verinurad | Denmark | DK2776028 | 2031-11-03 | ⤷ Try a Trial |
Verinurad | Eurasian Patent Organization | EA026101 | 2031-11-03 | ⤷ Try a Trial |
>Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |